Mika Terao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mika Terao has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Ichiro Katayama
Department of Dermatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, Japan
15 shared publicationsHiroyuki Murota
Department of Dermatology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan
10 shared publications- Ichiro Katayama
Department of Pigmentation Research and Therapeutics Osaka City University Osaka Japan
8 shared publications - Hiroyuki Murota
Department of Dermatology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan
7 shared publications Sayaka Matsumura
7 shared publicationsSaori Itoi
6 shared publications
Latest Publications
- 28 June 2019
- Published by Springer Nature in Journal of the Association for Research in Otolaryngology
- Vol. 20 (5) , 449-459
Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling
Cholesteatoma starts as a retraction of the tympanic membrane and expands into the middle ear, eroding the surrounding bone and causing hearing loss and other serious complications such as brain abscess and meningitis. Currently, the only effective treatment is complete surgical removal, but the recurrence rate is relatively high. In rheumatoid arthritis (RA), osteoclasts are known to be responsible for bone erosion and undergo differentiation and activation by receptor activator of NF-κB ligand (RANKL), which is secreted by synovial fibroblasts, T cells, and B cells. On the other hand, the mechanism of bone erosion in cholesteatoma is still controversial. In this study, we found that a significantly larger number of osteoclasts were observed on the eroded bone adjacent to cholesteatomas than in unaffected areas, and that fibroblasts in the cholesteatoma perimatrix expressed RANKL. We also investigated upstream transcription factors of RANKL using RNA sequencing results obtained via Ingenuity Pathways Analysis, a tool that identifies relevant targets in molecular biology systems. The concentrations of four candidate factors, namely interleukin-1β, interleukin-6, tumor necrosis factor α, and prostaglandin E2, were increased in cholesteatomas compared with normal skin. Furthermore, interleukin-1β was expressed in infiltrating inflammatory cells in the cholesteatoma perimatrix. This is the first report demonstrating that a larger-than-normal number of osteoclasts are present in cholesteatoma, and that the disease involves upregulation of factors related to osteoclast activation. Our study elucidates the molecular basis underlying bone erosion in cholesteatoma.
- 28 June 2019
- Published by Springer Nature in Journal of the Association for Research in Otolaryngology
- Vol. 20 (5) , 449-459
Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling
Cholesteatoma starts as a retraction of the tympanic membrane and expands into the middle ear, eroding the surrounding bone and causing hearing loss and other serious complications such as brain abscess and meningitis. Currently, the only effective treatment is complete surgical removal, but the recurrence rate is relatively high. In rheumatoid arthritis (RA), osteoclasts are known to be responsible for bone erosion and undergo differentiation and activation by receptor activator of NF-κB ligand (RANKL), which is secreted by synovial fibroblasts, T cells, and B cells. On the other hand, the mechanism of bone erosion in cholesteatoma is still controversial. In this study, we found that a significantly larger number of osteoclasts were observed on the eroded bone adjacent to cholesteatomas than in unaffected areas, and that fibroblasts in the cholesteatoma perimatrix expressed RANKL. We also investigated upstream transcription factors of RANKL using RNA sequencing results obtained via Ingenuity Pathways Analysis, a tool that identifies relevant targets in molecular biology systems. The concentrations of four candidate factors, namely interleukin-1β, interleukin-6, tumor necrosis factor α, and prostaglandin E2, were increased in cholesteatomas compared with normal skin. Furthermore, interleukin-1β was expressed in infiltrating inflammatory cells in the cholesteatoma perimatrix. This is the first report demonstrating that a larger-than-normal number of osteoclasts are present in cholesteatoma, and that the disease involves upregulation of factors related to osteoclast activation. Our study elucidates the molecular basis underlying bone erosion in cholesteatoma.
- 1 May 2017
- Published by Elsevier in Journal of Dermatological Science
- Vol. 86 (2) , e90
Local cortisol activation is involved in EGF-induced immunosuppression
- 1 May 2017
- Published by Elsevier in Journal of Dermatological Science
- Vol. 86 (2) , e90
Local cortisol activation is involved in EGF-induced immunosuppression
- Open Access
- 1 January 2017
- Published by Taylor & Francis in Dermato-Endocrinology
- Vol. 9 (1) , e1412018
Local cortisol activation is involved in EGF-induced immunosuppression
The major effects of the epidermal growth factor receptor (EGFR) signalling pathway on keratinocytes are cell proliferation, cell differentiation, and wound healing. In addition to these effects, an immunosuppressive effect of EGFR signalling has been reported. However, the precise mechanism of immunosuppression by EGFR signalling is not well understood. In this study, we clarified the involvement of increased local cortisol activation in EGFR signalling-induced immunosuppression in keratinocytes. EGF treatment up-regulated the expression of 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) and supernatant cortisol levels in a dose-dependent manner in keratinocytes. 11β-HSD1 is an enzyme that catalyses the conversion of cellular hormonally inactive cortisone into active cortisol. qRT-PCR and ELISA assays indicated that EGF significantly decreased tumour necrosis factor α (TNF- α)-induced interleukin-6 (IL-6) expression in keratinocytes. Similarly, 11β-HSD1 overexpression significantly decreased TNF-α-induced IL-6 expression. We evaluated the role of 11β-HSD1 in immunosuppression through EGFR signalling. Blockade of 11β-HSD1 via 11β-HSD1 inhibitor reversed both the expression and production of TNF-α-induced IL-6, which was decreased by EGF in keratinocytes. Therefore, increased local cortisol activation by 11β-HSD1 is involved in EGFR signalling-induced immunosuppression in keratinocytes. Finally, we evaluated whether EGFR inhibition by cetuximab affects the expression of 11β-HSD1. We found that 0.1 µg cetuximab decreased 11β-HSD1 transcript levels in keratinocytes. The changes in 11β-HSD1 were more apparent in TNF-α-treated cells. As 11β-HSD1 expression in keratinocytes is associated with inflammation and cell proliferation, this mechanism may be associated with adverse skin reactions observed in patients treated with EGFR inhibitors.
- 1 January 2017
- Published by Taylor & Francis in Dermato-Endocrinology
- Vol. 9 (1) , e1412018
Open AccessLocal cortisol activation is involved in EGF-induced immunosuppression
The major effects of the epidermal growth factor receptor (EGFR) signalling pathway on keratinocytes are cell proliferation, cell differentiation, and wound healing. In addition to these effects, an immunosuppressive effect of EGFR signalling has been reported. However, the precise mechanism of immunosuppression by EGFR signalling is not well understood. In this study, we clarified the involvement of increased local cortisol activation in EGFR signalling-induced immunosuppression in keratinocytes. EGF treatment up-regulated the expression of 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) and supernatant cortisol levels in a dose-dependent manner in keratinocytes. 11β-HSD1 is an enzyme that catalyses the conversion of cellular hormonally inactive cortisone into active cortisol. qRT-PCR and ELISA assays indicated that EGF significantly decreased tumour necrosis factor α (TNF- α)-induced interleukin-6 (IL-6) expression in keratinocytes. Similarly, 11β-HSD1 overexpression significantly decreased TNF-α-induced IL-6 expression. We evaluated the role of 11β-HSD1 in immunosuppression through EGFR signalling. Blockade of 11β-HSD1 via 11β-HSD1 inhibitor reversed both the expression and production of TNF-α-induced IL-6, which was decreased by EGF in keratinocytes. Therefore, increased local cortisol activation by 11β-HSD1 is involved in EGFR signalling-induced immunosuppression in keratinocytes. Finally, we evaluated whether EGFR inhibition by cetuximab affects the expression of 11β-HSD1. We found that 0.1 µg cetuximab decreased 11β-HSD1 transcript levels in keratinocytes. The changes in 11β-HSD1 were more apparent in TNF-α-treated cells. As 11β-HSD1 expression in keratinocytes is associated with inflammation and cell proliferation, this mechanism may be associated with adverse skin reactions observed in patients treated with EGFR inhibitors.
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e64
Oligosaccharide modification by GnT-V augments oxazolone-induced atopic dermatitis-like symptoms
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e64
Oligosaccharide modification by GnT-V augments oxazolone-induced atopic dermatitis-like symptoms
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e38-e39
The role of 11β-hydroxysteroid dehydrogenase 1 in UVB-induced skin inflammation
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e38-e39
The role of 11β-hydroxysteroid dehydrogenase 1 in UVB-induced skin inflammation
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e43
Th2 cytokines enhance TrkA expression and upregulate proliferation and downregulate differentiation of keratinocytes
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e43
Th2 cytokines enhance TrkA expression and upregulate proliferation and downregulate differentiation of keratinocytes
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e134
Sandalwood oil downregulates skin inflammation through 11β-HSD1 activation in keratinocytes
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e134
Sandalwood oil downregulates skin inflammation through 11β-HSD1 activation in keratinocytes
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , 11-16
Local cortisol/corticosterone activation in skin physiology and pathology
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , 11-16
Local cortisol/corticosterone activation in skin physiology and pathology
- 1 June 2016
- Published by Elsevier in The American Journal of Pathology
- Vol. 186 (6) , 1499-1510
Local Glucocorticoid Activation by 11β-Hydroxysteroid Dehydrogenase 1 in Keratinocytes
- 1 June 2016
- Published by Elsevier in The American Journal of Pathology
- Vol. 186 (6) , 1499-1510
Local Glucocorticoid Activation by 11β-Hydroxysteroid Dehydrogenase 1 in Keratinocytes
- Open Access
- 5 January 2016
- Published by Taylor & Francis in Dermato-Endocrinology
- Vol. 8 (1) , e1119958
Local corticosterone activation by 11β-hydroxysteroid dehydrogenase 1 in keratinocytes: the role in narrow-band UVB-induced dermatitis
Keratinocytes are known to synthesize cortisol through activation of the enzyme 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1). To confirm the function of 11β-HSD1 in keratinocytes during inflammation in vivo, we created keratinocyte-specific-11β-HSD1 knockout mice (K5-Hsd11b1-KO mice) and analyzed the response to narrow-band ultraviolet B (NB-UVB) irradiation. Firstly, we measured the mRNA and protein levels of 11β-HSD1 following NB-UVB irradiation and found that the expression of 11β-HSD1 in keratinocytes of mouse ear skin was enhanced at 3 and 24 hours after 250 mJ/cm2, 500 mJ/cm2, 1 J/cm2, and 2 J/cm2 NB-UVB irradiation. Next, we determined that 24 hours after exposure to 1 J/cm2 NB-UVB irradiation, the numbers of F4/80-, CD45-, and Gr-1-positive cells were increased in K5-Hsd11b1-KO mice compared to wild type (WT) mice. Furthermore, the expression of the chemokine (C-X-C-motif) ligand 1 (CXCL1) and interleukin (IL)-6 was also significantly enhanced in NB-UVB-irradiated K5-Hsd11b1-KO mice compared with WT mice. In addition, activation of nuclear factor-kappa B (NF-κB) after NB-UVB irradiation was enhanced in K5-Hsd11b1-KO mice compared to that in WT mice. Thus, NB-UVB-induced inflammation is augmented in K5-Hsd11b1-KO mice compared with WT mice. These results indicate that 11β-HSD1 may suppress NB-UVB-induced inflammation via inhibition of NF-κB activation.
- 5 January 2016
- Published by Taylor & Francis in Dermato-Endocrinology
- Vol. 8 (1) , e1119958
Open AccessLocal corticosterone activation by 11β-hydroxysteroid dehydrogenase 1 in keratinocytes: the role in narrow-band UVB-induced dermatitis
Keratinocytes are known to synthesize cortisol through activation of the enzyme 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1). To confirm the function of 11β-HSD1 in keratinocytes during inflammation in vivo, we created keratinocyte-specific-11β-HSD1 knockout mice (K5-Hsd11b1-KO mice) and analyzed the response to narrow-band ultraviolet B (NB-UVB) irradiation. Firstly, we measured the mRNA and protein levels of 11β-HSD1 following NB-UVB irradiation and found that the expression of 11β-HSD1 in keratinocytes of mouse ear skin was enhanced at 3 and 24 hours after 250 mJ/cm2, 500 mJ/cm2, 1 J/cm2, and 2 J/cm2 NB-UVB irradiation. Next, we determined that 24 hours after exposure to 1 J/cm2 NB-UVB irradiation, the numbers of F4/80-, CD45-, and Gr-1-positive cells were increased in K5-Hsd11b1-KO mice compared to wild type (WT) mice. Furthermore, the expression of the chemokine (C-X-C-motif) ligand 1 (CXCL1) and interleukin (IL)-6 was also significantly enhanced in NB-UVB-irradiated K5-Hsd11b1-KO mice compared with WT mice. In addition, activation of nuclear factor-kappa B (NF-κB) after NB-UVB irradiation was enhanced in K5-Hsd11b1-KO mice compared to that in WT mice. Thus, NB-UVB-induced inflammation is augmented in K5-Hsd11b1-KO mice compared with WT mice. These results indicate that 11β-HSD1 may suppress NB-UVB-induced inflammation via inhibition of NF-κB activation.